Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

News Daily News

Weight Loss Drugs Show Promise for Secondary Prevention in PAD

L.A. McKeown

February 04, 2026

News Daily News

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

Caitlin E. Cox

October 22, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

News Opinion CV Team Dispatch

March 2025 Dispatch for the CV Team

L.A. McKeown

March 21, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2024

Shelley Wood

May 31, 2024

News Opinion CV Team Dispatch

February 2024 Dispatch for the CV Team

L.A. McKeown

February 01, 2024

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

Michael O'Riordan

September 09, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Daily News

AI-Enabled Algorithm Succeeds in Identifying Diabetes From ECG Data

Yael L. Maxwell

August 12, 2022

News Daily News

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

Michael O'Riordan

August 11, 2022

News Daily News

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

Michael O'Riordan

July 05, 2022

News Conference News EAS 2022

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

Michael O'Riordan

May 26, 2022

News Conference News EAS 2022

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Michael O'Riordan

May 24, 2022

News Conference News EuroPCR 2022

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Michael O'Riordan

May 23, 2022

News Daily News

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Michael O'Riordan

May 09, 2022

News Conference News TCT 2021

‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients

Yael L. Maxwell

November 04, 2021

News Conference News VIVA 2021

Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI

L.A. McKeown

October 08, 2021

News Daily News

Patient-Level Data Strengthen Rosiglitazone-CV Link: Meta-analysis

Caitlin E. Cox

February 07, 2020

Advertisement

Weight Loss Drugs Show Promise for Secondary Prevention in PAD

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

April 2025 Dispatch for the CV Team

March 2025 Dispatch for the CV Team

TCTMD’s Top 10 Most Popular Stories for May 2024

February 2024 Dispatch for the CV Team

October 2023 News Roundup

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

What’s Going to Be Hot at ESC 2022?

AI-Enabled Algorithm Succeeds in Identifying Diabetes From ECG Data

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients

Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI

Patient-Level Data Strengthen Rosiglitazone-CV Link: Meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content